Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03704207 · ClinicalTrials.gov registry record · NA
Utility of PCD Diagnostics to Improve Clinical Care
A NA study of Primary Ciliary Dyskinesia, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03704207: Recruiting NA study of Primary Ciliary Dyskinesia, sponsored by Vanderbilt University Medical Center.
NCT03704207 is a NA study of Primary Ciliary Dyskinesia that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 200 participants, above the 82-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (144% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03704207, a NA study of Primary Ciliary Dyskinesia, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Primary Outcome
number of tests
Conditions Studied
Interventions
- OTHER nNO testing
Study Locations (1)
Tennessee
- Vanderbilt Children's hospital - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What NCT03704207 shows while recruiting
NCT03704207 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (144% higher).
The record links to 1 condition, with Primary Ciliary Dyskinesia appearing as the primary indexed condition, and to 1 intervention - of which nNO testing is the first listed.
NCT03704207 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03704207 about?
NCT03704207 is a clinical study titled "Utility of PCD Diagnostics to Improve Clinical Care". This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
What is the current status of trial NCT03704207?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2017-06-01. Estimated completion is 2028-06-01.
What conditions does trial NCT03704207 study?
This clinical trial studies the following conditions: Primary Ciliary Dyskinesia.
What interventions are being tested in trial NCT03704207?
The interventions under investigation include: nNO testing (OTHER).
Who is sponsoring clinical trial NCT03704207?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03704207 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Ciliary Dyskinesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
RECRUITING
-
Utility of PCD Diagnostics to Improve Clinical Care
RECRUITING
-
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
ACTIVE NOT RECRUITING
-
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
ACTIVE NOT RECRUITING
-
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI